Sandra Horning
CIK: 0001638709
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 18, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct1.2K shares- - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
29.5K shares- - May 6, 2026MRNA
Moderna, Inc.
Award(A)DirectRestricted Stock Units
2.1K shares- - May 6, 2026MRNA
Moderna, Inc.
Award(A)DirectStock Option (Right to Buy)
9.7K shares- - Apr 30, 2026MRNA
Moderna, Inc.
Exercise(M)Direct16.2K shares- - Apr 30, 2026GILD
GILEAD SCIENCES, INC.
Award(A)Direct1.1K shares- - Jun 26, 2025RVMD
Revolution Medicines, Inc.
Award(A)Direct3.1K shares- - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
24.2K shares- - May 7, 2025GILD
GILEAD SCIENCES, INC.
Award(A)Direct1.5K shares- - Apr 30, 2025MRNA
Moderna, Inc.
Award(A)DirectRestricted Stock Units
16.2K shares- - Apr 30, 2025MRNA
Moderna, Inc.
Exercise(M)Direct979 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  RVMD Revolution Medicines, Inc. | Award(A) | 1,191 | - | $0 | Direct |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 29,500 | - | - | Direct |
| May 6, 2026 |  MRNA Moderna, Inc. | Award(A) Restricted Stock Units | 2,092 | - | - | Direct |
| May 6, 2026 | MRNA Moderna, Inc. | Award(A) Stock Option (Right to Buy) | 9,681 | - | - | Direct |
| Apr 30, 2026 | MRNA Moderna, Inc. | Exercise(M) | 16,233 | - | $0 | Direct |
| Apr 30, 2026 |  GILD GILEAD SCIENCES, INC. | Award(A) | 1,146 | - | $0 | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award(A) | 3,142 | - | - | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 24,150 | - | - | Direct |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | Award(A) | 1,516 | - | - | Direct |
| Apr 30, 2025 | MRNA Moderna, Inc. | Award(A) Restricted Stock Units | 16,233 | - | - | Direct |
| Apr 30, 2025 | MRNA Moderna, Inc. | Exercise(M) | 979 | - | - | Direct |
1-11 of 11 transactions
About Horning Sandra
Horning Sandra (SEC CIK 0001638709) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD), Director of Olema Pharmaceuticals, Inc. (OLMA) and Director of Moderna, Inc. (MRNA). Signal8 also holds filings tied to 1 other company.
Signal8 holds 9 ownership filings by Horning Sandra, all Form 4s, filed between May 1, 2025 and Jun 23, 2026. Those filings report 11 transactions, from Apr 30, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Horning Sandra's filings is in SAN FRANCISCO, CA.
Recent filings by Horning Sandra
- Jun 18, 2026: Grant or award of RVMD shares (Form 4, code A).
- Jun 18, 2026: Grant or award of OLMA derivative securities (Form 4, code A).
- May 6, 2026: Grants or awards of MRNA derivative securities (2 lines, Form 4, code A).
- Apr 30, 2026: Option exercise of MRNA shares (Form 4, code M).
- Apr 30, 2026: Grant or award of GILD shares (Form 4, code A).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer